The article discusses the potential cybersecurity risks associated with mergers and acquisitions (M&A) in the healthcare sector. It highlights the need for organizations to implement stringent security checks and due diligence to mitigate possible threats and ensure data protection. The report implies a strong “buyer beware” warning for these dealmakers.
Chroma Medicine, Nvelop Therapeutics Merge as nChroma Bio with Focus on Epigenetic Therapies for Liver Disease
Biotech firms Chroma Medicine and Nvelop Therapeutics have merged to form nChroma Bio, which will develop gene-editing therapies. The new company raised $75m in a
